InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2023-08-07 00:00:00 ET · period of report 2023-08-03 · accession 0001438133-23-000157 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-08-07 2023-08-03 TNDM Howell Peyton R Dir M - OptEx $0.00 +949 12.3K +8% $0
D 2023-08-07 2023-08-03 TNDM Howell Peyton R Dir M - OptEx $0.00 -949 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-03 M A 949 $0.00 12,256 D — —
2 Derivative Restricted Stock Unit 2023-08-03 M D 949 $0.00 0 D — · — to — 949 Common Stock (F1) Awarded on August 3, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). (F2) Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. (F3) This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.